Position (Postdoctoral) in Immunopharmacology, Australia

David Joyce djoyce at receptor.pharm.uwa.edu.au
Mon Aug 15 04:00:03 EST 1994


               POSTDOCTORAL POSITION IN IMMUNOPHARMACOLOGY 
           DEPT OF PHARMACOLOGY, UNIVERSITY OF WESTERN AUSTRALIA
This position is offered in a group with interests in both clinical and 
basic research in inflammatory joint disease. The appointee will coordinate 
a project examining glucocorticoid modulation of monokine production (
especially TNF-alpha) at cellular and molecular levels, with special 
reference to factors influencing clinical glucocorticoid responsiveness. 
Good laboratory facilities and opportunities for outside collaboration are 
available. Applicants require a PhD, a history of productivity in research, 
a background either in immunology or glucocorticoid pharmacology and 
experience in cell biology or molecular biology. The appointment will be for 
an initial period of two years. Some assistance towards relocation expenses (
if applicable) may be negotiated.  The appointment is at the level of 
research officer or senior research officer, with salary range from A$37,897 
to A$42,341. Currently A$1 = approx US$0.74.
We are in Perth, in Western Australia. The department is on the campus of a 
600 bed teaching hospital, and includes the department of clinical 
pharmacology (two physicians) of the hospital, together with other groups 
with interests in various areas of basic pharmacology. Perth is an 
attractive, medium-sized coastal city with excellent climate and geography 
for an outdoors lifestyle, especially sailing, surfing, beachgoing, etc. 
Extra information can be obtained from David A Joyce MD at the following 
addresses:Dept of Pharmacology, University of Western Australia,
Nedlands, 6009, Australia
Email: djoyce at receptor.pharm.uwa.edu.au
Fax:  +619 3463469   Phone: +619 346 3682 (Time here = 8 hr earlier than 
GMT, no daylight saving applying)
Applications, including CV and the names of at least two referees 
should be made to one of these addresses as soon as possible. 



More information about the Immuno mailing list